Site navigation

Navigation

Brain cancer - temozolomide

Temozolomide for the treatment of recurrent malignant glioma (brain cancer)

Summary

People with recurrent brain cancer who's initial chemotherapy treatment has failed (either because it was not effective or because it caused side effects) may be considered for treatment with temozolomide, when  they have a tumour that it has been shown is malignant through microscopic exami ...

Read the complete summary


Guidance documents

Implementing this guidance

  • No documents found

About this guidance

Technology appraisals TA23

Issued: April 2001

See related guidance:

See this guidance in practice:

Order printed copies of this guidance